UF Health Cancer Center Achieves National Cancer Institute Designation
The University of Florida Health Cancer Center has received a prestigious designation from the National Cancer Institute, or NCI, and joins the ranks of the country’s most distinguished cancer centers, becoming the 72nd in the United States and the only one in North Central Florida.
EU Adds 9 Startups to Contribute Data to Copernicus Mission
The European Union (EU) has added nine startups — including Spain-based Satlantis, the parent company of UF startup Satlantis LLC — to contribute data to the Copernicus project. Each startup will receive a 5 million euro contract to provide additional data to Copernicus.
UF Startups Among Companies Selected for U.S. Funding to Reduce Carbon Emissions
UF startup Micro Nano Technologies, incubating at UF Innovate | Accelerate at The Hub, is one of six companies sharing $16.2 million in funding for decarbonizing paper and forest products. The goal is to reduce net energy GHG emissions in the paper and forest products industry including increasing the share of renewable energy used, electrification, carbon capture, and energy efficiency.
Tech Tuesday: Oneness Technologies
In this week’s Tech Tuesday featured on WCJB TV20, we interview Dr. Neha Chavan and Alex Blanton from Oneness Technologies, a biotech company that combines cutting-edge scientific expertise with a plant-based medicine approach. The startup’s technology revolutionizes the health and wellness industry by ensuring maximum absorption of hemp products in the body, minimizing wastage, and reducing side effects.
Neobiosis Announces FDA Approval of IND for Use of ViXomeTM in COVID-19 ‘Post COVID Syndrome’
Neobiosis, A UF Accelerate resident client, is a leading research and manufacturing biotechnology company focused on pioneering the development of novel therapeutics from perinatal tissues as a new class of medicines. Today, Neobiosis announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for ViXome™, its drug for the treatment of ‘Post COVID Syndrome (AKA “Long Haul COVID Syndrome”).
Tech Tuesday: Fire Neural Network
In this week’s Tech Tuesday, we interview
Dr. Istvan Kereszy, CEO of Fire Neural Network (FNN), to explore their groundbreaking work in lighting detection and its crucial role in preventing wildfires. Hear how their advanced technological detectors can identify high-risk strikes and are helping mitigate fires.
UF Innovate Inventor Receives NIH R21 Award to Explore Human Cell Behaviors
UF Innovate Inventor, Josephine Allen, Ph.D., associate professor and Genzyme Professor of Materials Science & Engineering, has received a National Institutes of Health (NIH) R21 Award to better understand the native behaviors of cells in the human body.
UF Innovate Researchers Secure $3.8M NIH Grant To Combat Psoriasis
UF Innovate Inventors, Dr. Benjamin Keselowsky (PI), Dr. Gregory Hudalla (Co-I), and their collaborators have received a $3.8M grant from the NIH National Institute of Allergy and Infectious Diseases. The grant aims to address the problem of psoriasis, a chronic auto-inflammatory disease that causes irreversible damage to the skin.
UF Scientists See Bright Future As They Seek Savory Strawberries – And High Yield
In a newly published paper, led by Mark Porter and co-authored by UF Innovate inventor Vance Whitaker, is helping outline the past, present and potential future of breeding flavor into strawberries.
Fixel Institute Becomes the First National Ataxia Foundation Center of Excellence in Florida
The National Ataxia Foundation (NAF) announces the recognition of the Norman Fixel Institute for Neurological Disease at UF Health as a NAF Ataxia Center of Excellence (CoE), making it the first CoE in the state of Florida and one of 15 nationwide.